News
Hosted on MSN3mon
Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz SegmentThermo Fisher Scientific is expanding its life sciences ... This business segment provides reagents, instruments, and consumables used in medical research, drug and vaccine R&D, and diagnosis ...
Amidst stagnant revenue and a recently slashed growth forecast, Thermo Fisher Scientific (TMO-3.10%) is having a rough 2023. Its shares are down by 19% so far this year, a startling departure from ...
--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader ... The system’s compatibility with a wide range of reagents and antibodies enables seamless integration into existing ...
Thermo Fisher Scientific Inc. provides life sciences ... The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research ...
Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its ...
Thermo Fisher expects 2025 adjusted profit in the range of $21.76 and $22.84 per share, compared with its previous forecast of $23.10 to $23.50 and analysts' average expectation of $23.25 ...
AIC-CCMB and Thermo Fisher Scientific launched a Supply Centre in Hyderabad to provide researchers real-time access to lab ...
The supply centre, located at CCMB Annexe 2 and inaugurated by CCMB director Dr Vinay Kumar Nandicoori on Wednesday, will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results